• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3-硝基丙酸的致命三联征:神经退行性变的协同途径。

3-Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration.

作者信息

Alexi T, Hughes P E, Faull R L, Williams C E

机构信息

Research Centre for Developmental Medicine and Biology, School of Medicine, Starship Hospital, University of Auckland, New Zealand.

出版信息

Neuroreport. 1998 Aug 3;9(11):R57-64. doi: 10.1097/00001756-199808030-00001.

DOI:10.1097/00001756-199808030-00001
PMID:9721909
Abstract

3-Nitropropionic acid (3-NP) is a mitochondrial toxin which interferes with ATP synthesis. Accidental ingestion of 3-NP by humans as well as other mammals results in neuronal degeneration within the basal ganglia and movement dysfunction characterized by dystonia, chorea, and hypokinesia. The selective degeneration of structures of the basal ganglia occurs despite the non-selective impairment of energy metabolism throughout the brain and body. These effects of 3-NP are shared with the genetic disorder Huntington's disease (HD), which is characterized by progressive neurodegeneration of the basal ganglia and choreic motor dysfunction. These similarities have prompted further investigation of 3-NP as an animal model of HD. Metabolic compromise with 3-NP causes neurodegeneration that involves three interacting processes: energy impairment, excitotoxicity, and oxidative stress. This triplet of cooperative pathways of neurodegeneration helps to explain 3-NP's regional selectivity of neurotoxicity to the basal ganglia. This mini-review will focus on the actions of 3-NP and the related compound, malonic acid (MA), in the central nervous system, with an emphasis on the more current findings regarding their mechanisms of action.

摘要

3-硝基丙酸(3-NP)是一种干扰ATP合成的线粒体毒素。人类以及其他哺乳动物意外摄入3-NP会导致基底神经节内的神经元变性以及以肌张力障碍、舞蹈症和运动迟缓为特征的运动功能障碍。尽管大脑和身体的能量代谢受到非选择性损害,但基底神经节结构仍会发生选择性退化。3-NP的这些作用与遗传性疾病亨廷顿舞蹈症(HD)相同,后者的特征是基底神经节进行性神经变性和舞蹈样运动功能障碍。这些相似之处促使人们进一步研究将3-NP作为HD的动物模型。3-NP导致的代谢损害会引起神经变性,这涉及三个相互作用的过程:能量损伤、兴奋性毒性和氧化应激。这种神经变性的三联协同途径有助于解释3-NP对基底神经节神经毒性的区域选择性。这篇综述将重点关注3-NP和相关化合物丙二酸(MA)在中枢神经系统中的作用,重点是关于它们作用机制的最新研究结果。

相似文献

1
3-Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration.3-硝基丙酸的致命三联征:神经退行性变的协同途径。
Neuroreport. 1998 Aug 3;9(11):R57-64. doi: 10.1097/00001756-199808030-00001.
2
Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies.大鼠对线粒体毒素3-硝基丙酸慢性全身给药反应的主要品系差异:对神经保护研究的启示
Neuroscience. 2000;97(3):521-30. doi: 10.1016/s0306-4522(00)00020-8.
3
3-Nitropropionic acid animal model and Huntington's disease.3-硝基丙酸动物模型与亨廷顿病
Neurosci Biobehav Rev. 1997 May;21(3):289-93. doi: 10.1016/s0149-7634(96)00027-9.
4
Potential of protease inhibitor in 3-nitropropionic acid induced Huntington's disease like symptoms: mitochondrial dysfunction and neurodegeneration.蛋白酶抑制剂在3-硝基丙酸诱导的亨廷顿氏病样症状中的潜力:线粒体功能障碍和神经退行性变。
Neurotoxicology. 2014 Dec;45:139-48. doi: 10.1016/j.neuro.2014.10.004. Epub 2014 Oct 16.
5
Chrysin exerts neuroprotective effects against 3-Nitropropionic acid induced behavioral despair-Mitochondrial dysfunction and striatal apoptosis via upregulating Bcl-2 gene and downregulating Bax-Bad genes in male wistar rats.白杨素通过上调雄性Wistar大鼠的Bcl-2基因和下调Bax-Bad基因,对3-硝基丙酸诱导的行为绝望、线粒体功能障碍和纹状体细胞凋亡发挥神经保护作用。
Biomed Pharmacother. 2016 Dec;84:514-525. doi: 10.1016/j.biopha.2016.09.070. Epub 2016 Sep 28.
6
Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease.睡茄根提取物对3-硝基丙酸诱导的亨廷顿舞蹈病动物模型行为、生化及线粒体功能障碍的潜在神经保护作用。
J Med Food. 2009 Jun;12(3):591-600. doi: 10.1089/jmf.2008.0028.
7
Systemic, but not intraparenchymal, administration of 3-nitropropionic acid mimics the neuropathology of Huntington's disease: a speculative explanation.3-硝基丙酸的全身给药而非脑实质内给药模拟了亨廷顿舞蹈病的神经病理学:一种推测性解释。
Neurosci Res. 1997 Jul;28(3):185-9. doi: 10.1016/s0168-0102(97)00045-x.
8
Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.长期用3-硝基丙酸治疗的大鼠出现可量化的运动迟缓、步态异常及亨廷顿舞蹈病样纹状体损伤。
Neuroscience. 1997 Jul;79(1):45-56. doi: 10.1016/s0306-4522(96)00602-1.
9
ADIOL protects against 3-NP-induced neurotoxicity in rats: Possible impact of its anti-oxidant, anti-inflammatory and anti-apoptotic actions.ADIOL 可预防 3-NP 诱导的大鼠神经毒性:其抗氧化、抗炎和抗细胞凋亡作用的可能影响。
Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jul 3;60:36-51. doi: 10.1016/j.pnpbp.2015.02.005. Epub 2015 Feb 14.
10
An Overview of the Pathophysiological Mechanisms of 3-Nitropropionic Acid (3-NPA) as a Neurotoxin in a Huntington's Disease Model and Its Relevance to Drug Discovery and Development.3-硝基丙酸(3-NPA)作为亨廷顿舞蹈病模型中的神经毒素的病理生理机制概述及其与药物发现和开发的相关性
Neurochem Res. 2023 Jun;48(6):1631-1647. doi: 10.1007/s11064-023-03868-1. Epub 2023 Feb 4.

引用本文的文献

1
Sesamol: A Phenolic Compound of Health Benefits and Therapeutic Promise in Neurodegenerative Diseases.芝麻酚:一种具有健康益处和神经退行性疾病治疗潜力的酚类化合物。
Curr Top Med Chem. 2024;24(9):797-809. doi: 10.2174/0115680266273944231213070916.
2
Identification of cyclin D1 as a major modulator of 3-nitropropionic acid-induced striatal neurodegeneration.鉴定细胞周期蛋白 D1 为 3-硝基丙酸诱导的纹状体神经退行性变的主要调节因子。
Neurobiol Dis. 2022 Jan;162:105581. doi: 10.1016/j.nbd.2021.105581. Epub 2021 Dec 3.
3
Expanding the Arsenal Against Huntington's Disease-Herbal Drugs and Their Nanoformulations.
扩充亨廷顿病治疗武器库——草药药物及其纳米制剂。
Curr Neuropharmacol. 2021;19(7):957-989. doi: 10.2174/1570159X18666201109090824.
4
Succinate accumulation induces mitochondrial reactive oxygen species generation and promotes status epilepticus in the kainic acid rat model.琥珀酸积累诱导线粒体活性氧产生,并促进海人酸大鼠模型的癫痫持续状态。
Redox Biol. 2020 Jan;28:101365. doi: 10.1016/j.redox.2019.101365. Epub 2019 Oct 31.
5
Protective Effects of Antioxidants in Huntington's Disease: an Extensive Review.抗氧化剂在亨廷顿病中的保护作用:一篇综述。
Neurotox Res. 2019 Apr;35(3):739-774. doi: 10.1007/s12640-018-9989-9. Epub 2019 Jan 11.
6
Cilostazol disrupts TLR-4, Akt/GSK-3β/CREB, and IL-6/JAK-2/STAT-3/SOCS-3 crosstalk in a rat model of Huntington's disease.西洛他唑破坏了亨廷顿病大鼠模型中的 TLR-4、Akt/GSK-3β/CREB 和 IL-6/JAK-2/STAT-3/SOCS-3 串扰。
PLoS One. 2018 Sep 27;13(9):e0203837. doi: 10.1371/journal.pone.0203837. eCollection 2018.
7
Comparison of the Toxic Effects of Quinolinic Acid and 3-Nitropropionic Acid in C. elegans: Involvement of the SKN-1 Pathway.喹啉酸和 3-硝基丙酸在秀丽隐杆线虫中的毒性效应比较:SKN-1 通路的参与。
Neurotox Res. 2018 Feb;33(2):259-267. doi: 10.1007/s12640-017-9794-x. Epub 2017 Aug 18.
8
Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats.芦丁对线粒体毒素3-硝基丙酸诱导的生化、行为和组织学改变的影响——大鼠亨廷顿病模型的初步研究
Metab Brain Dis. 2017 Apr;32(2):471-481. doi: 10.1007/s11011-016-9929-4. Epub 2016 Dec 8.
9
Animal models of multiple system atrophy.多系统萎缩的动物模型
Clin Auton Res. 2015 Feb;25(1):9-17. doi: 10.1007/s10286-014-0266-6. Epub 2015 Jan 14.
10
Plants and phytochemicals for Huntington's disease.用于治疗亨廷顿舞蹈症的植物及植物化学物质。
Pharmacogn Rev. 2013 Jul;7(14):81-91. doi: 10.4103/0973-7847.120505.